Adjuvant

News

Related Video News

No related video news stories found.

Organic Broadcast Project

Related Videos

No related videos found.

Isolated Breast Cancer Cells In Sentinel Lymph Node Associated With Non-Sentinel Lymph Node Metastases

Published November 21, 2008, 3:16 pm, Science Daily

Women who are found to have isolated breast cancer cells upon sentinel lymph node biopsy have a risk of having metastases in other lymph nodes.

Discover News | Full Story


Epeius Biotechnologies announces results of Rexin-G in chem-resistant metastatic soft tissue sarcoma and osteosarcoma

Published November 21, 2008, 1:47 pm, News-Medical-Net

Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th annual meetings held in London UK on November 13-15, 2008.

Discover News | Full Story


(AFX UK Focus) 2008-11-21 11:01 UPDATE 1-Glaxo forms Chinese flu vaccine joint venture

Published November 21, 2008, 3:35 am, Interactive Investor

LONDON, Nov 21 (Reuters) - GlaxoSmithKline Plc formed a joint venture with China's Shenzhen Neptunus Interlong Bio-Technique (NBIT) to develop seasonal and pre-pandemic flu vaccines. The venture will first target strains of the influenza virus which are specific to China, Hong Kong and Macau. Within five years of the establishment of the venture, Glaxo has the option to increase its equity ...

Discover News | Full Story


Glaxo forms Chinese flu vaccine joint venture

Published November 21, 2008, 2:46 am, Reuters via Yahoo! Singapore News

* JV aimed at developing seasonal and pre-pandemic flu jabs

Discover News | Full Story


Rexin-G Controls Tumor Growth and Improves Survival in Chemotherapy-Resistant Soft Tissue Sarcoma and Osteosarcoma: ...

Published November 20, 2008, 5:49 pm, PR Newswire via Yahoo! Finance

Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr.

Discover News | Full Story


IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant

Published November 20, 2008, 8:00 am, PR Newswire via Yahoo! Finance

IDRI and Immune Design Corp. announced today that they have entered into an agreement pursuant to which Immune Design Corp. is granted a worldwide exclusive license for the research, development, and commercialization of IDRI's Glycopyranosyl Lipid Adjuvant technology for products targeting a number of indications.

Discover News | Full Story


Cedars Sinai Researchers Present New Findings At Neuroscience Meetings

Published November 20, 2008, 3:10 am, Medical News Today

Researchers from Cedars-Sinai Medical Center are presenting findings during the 38th annual meeting of the Society for Neuroscience. Neuroscience 2008 is at the Walter E. Washington Convention Center in Washington, D.C., Nov. 15 through 19, and is expected to draw more than 30,000 attendees from around the world.

Discover News | Full Story


CHMP recommends IDM Pharma's mifamurtide for bone tumour

Published November 20, 2008, 1:49 am, PharmaBiz

IDM Pharma, Inc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion, recommending grant of a centralized marketing authorization for mifamurtide (L-MTP-PE), known as Mepact in Europe, for the treatment of patients with non-metastatic, resectable osteosarcoma, a rare and often fatal bone tumour that ...

Discover News | Full Story


Caring for cats: When to vaccinate your feline friends -- and when not to

Published November 19, 2008, 5:48 pm, Detroit Free Press

Should you? Shouldn't you? Vaccinating your companion animal is an intensely personal decision that should be made in concert with your veterinarian. But it sure helps to have a little guidance along the way.

Discover News | Full Story


Anviron Successfully Completes First of Its Kind AquaSolv Contract for Usage as a Pesticide Carrier and Adjuvant

Published November 19, 2008, 11:06 am, Business Wire via Yahoo! Finance

IRVING, Texas----The Anviron Holding Company , a manufacturer and marketer of "Clean & Green" products and technology, announced today that it has successfully completed its first contract for the usage of AquaSolv product line as a Pesticide Carrier and Adjuvant with Geltz-Brunderlock Estates .

Discover News | Full Story



News Directory

Get started fast by using a pre-defined news directory category

Breaking News
and Top Stories
Business
Earnings, Economy, Personal Finance, and Stock Markets
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss
Politics
Congress, Supreme Court, and White House
Science
Animals, Astronomy, Biotechnology, Space, and Weather
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis
Technology
Communications, Hardware, Internet, Personal Technology, and Software
United States
and Crimes and Trials
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East


© Copyright 2005-2006 News Meme, All Rights Reserved | More News | Link Index | OSWD Design

Powered by Odin Assemble 2.5a